Interventional lung solutions refer to minimally invasive procedures and technologies designed to diagnose and treat lung conditions such as chronic obstructive pulmonary disease (COPD), lung cancer, and emphysema. These solutions typically include interventions such as bronchoscopy, endobronchial valves, and image-guided therapies, all aimed at improving lung function and enhancing patient outcomes.
The main types of interventional lung solutions include bronchoscopes, endobronchial ultrasound needles, pleuroscopes, airway stents, and other related devices. Bronchoscopes are medical instruments used to visualize and examine the airways and lungs, typically inserted through the nose or mouth to diagnose and treat respiratory conditions. Technologies associated with bronchoscopes include robotic surgery, laser therapy, and electromagnetic navigation bronchoscopy. The procedures involved include bronchoscopy, thoracoscopy, pleuroscopy, and others. These solutions are applied in various medical fields such as lung cancer treatment, COPD management, and sleep apnea treatment, and are used by a variety of end-users, including hospitals, ambulatory surgical centers, specialty clinics, and other healthcare settings.
The interventional lung solutions market research report is one of a series of new reports from The Business Research Company that provides interventional lung solutions market statistics, including the interventional lung solutions industry's global market size, regional shares, competitors with the interventional lung solutions market share, detailed interventional lung solutions market segments, market trends and opportunities, and any further data you may need to thrive in the interventional lung solutions market. This interventional lung solutions market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The interventional lung solutions market size has grown strongly in recent years. It will grow from $2.30 billion in 2024 to $2.49 billion in 2025 at a compound annual growth rate (CAGR) of 8.4%. The growth during the historic period can be attributed to the increasing prevalence of respiratory diseases, the growing number of smokers worldwide, rising air pollution levels, increasing healthcare awareness, and the growing number of lung cancer cases.
The interventional lung solutions market size is expected to see strong growth in the next few years. It will grow to $3.43 billion in 2029 at a compound annual growth rate (CAGR) of 8.3%. The growth in the forecast period can be attributed to the growing adoption of telemedicine and remote monitoring, an increasing focus on personalized medicine, the rising popularity of robotic-assisted surgery, the growing adoption of minimally invasive procedures, and an increasing focus on precision medicine. Major trends expected during this period include the development of advanced lung cancer interventions, the integration of artificial intelligence in bronchoscopy systems, the merging of interventional pulmonology with oncology treatments, the integration of digital platforms for lung disease management, and innovations in lung regeneration therapies.
The growing prevalence of respiratory diseases is expected to significantly drive the expansion of the interventional lung solutions market in the coming years. Respiratory diseases encompass a range of medical conditions that affect the lungs and airways, impairing breathing and disrupting normal respiratory function. The increase in respiratory diseases is largely attributed to rising levels of air pollution, which contribute to prolonged exposure to harmful airborne particles and irritants. Interventional lung solutions assist in managing these diseases by providing minimally invasive procedures that improve lung function and alleviate symptoms in patients with chronic pulmonary conditions. For example, in November 2023, the Centers for Disease Control and Prevention (CDC), a US-based government agency, reported approximately 8,331 tuberculosis cases in the United States in 2022, marking a 5.9% increase from the previous year. This growing prevalence of respiratory diseases is driving the growth of the interventional lung solutions market.
Key players in the interventional lung solutions market are focusing on the development of cutting-edge technologies, such as the Ion Endoluminal System, to enhance the accuracy of lung cancer diagnostics, enable minimally invasive procedures, and improve patient outcomes through advanced navigation and biopsy capabilities. The Ion Endoluminal System is a robotic-assisted platform designed for minimally invasive lung procedures, enabling precise airway navigation to access small or difficult-to-reach lung nodules. For example, in April 2024, the H. Lee Moffitt Cancer Center and Research Institute Foundation Inc., a US-based non-profit organization, launched a new Ion Robotic Bronchoscopy platform to enhance their interventional pulmonology program with advanced fiber-optic technology and a minimally invasive catheter system. This technology employs fiber optics and the smallest catheter available on the market to access all areas of the lungs. It features an ultra-thin, highly maneuverable catheter with 180° articulation, integrated real-time vision, and shape-sensing technology, enabling precise navigation and biopsy of peripheral lung nodules that are difficult to reach. This system offers unprecedented stability and accuracy for tissue sampling, enabling physicians to reach all 18 lung segments, thus improving the detection of early-stage lung cancer.
In February 2025, Stryker Corporation, a US-based medical device company, acquired Inari Medical Inc. for an undisclosed amount. This acquisition is aimed at strengthening Stryker's interventional endovascular portfolio by adding innovative thrombolytic-free solutions for treating venous thromboembolism (VTE), including pulmonary embolism and deep vein thrombosis. Inari Medical Inc., based in the US, specializes in providing interventional solutions for pulmonary conditions, with a particular focus on treating pulmonary embolism (PE).
Major players in the interventional lung solutions market are Johnson and Johnson, Siemens AG, Medtronic plc, FUJIFILM Holdings Corporation, GE Healthcare Technologies Inc., Boston Scientific Corporation, Olympus Corporation, Intuitive Surgical Inc., Smiths Medical Inc., Cook Medical Inc., Merit Medical Systems Inc., Penumbra Inc., Vygon SA, AngioDynamics Inc., Vapotherm Inc., Pulmonx Corporation, Broncus Medical Inc., Thirona B.V., Body Vision Medical Ltd., The Lung Docs Inc., EndoMed Systems GmbH.
North America was the largest region in the interventional lung solutions market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in interventional lung solutions report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the interventional lung solutions market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The interventional lung solutions market consists of revenues earned by entities by providing services such as endobronchial valve placement, navigational bronchoscopy, lung volume reduction, and airway stenting. The market value includes the value of related goods sold by the service provider or included within the service offering. The interventional lung solutions market also consists of sales of products including bronchial thermoplasty devices, cryotherapy devices, bronchial stents, and biopsy forceps. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Interventional Lung Solutions Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on interventional lung solutions market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for interventional lung solutions ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The interventional lung solutions market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Product Type: Bronchoscopes; Endobronchial Ultrasound Needles; Pleuroscopes; Airway Stents; Other Product Types
2) By Technology: Robotic Surgery; Laser Therapy; Electromagnetic Navigation Bronchoscopy
3) By Procedure: Bronchoscopy; Thoracoscopy; Pleuroscopy; Other Procedures
4) By Application: Lung Cancer Treatment; Chronic Obstructive Pulmonary Disease; Sleep Apnea Treatment
5) By End-User: Hospitals; Ambulatory Surgical Centers; Specialty Clinics; Other End-Users
Subsegments:
1) BY Bronchoscopes: Flexible Bronchoscopes; Rigid Bronchoscopes; Disposable Bronchoscopes
2) By Endobronchial Ultrasound Needles: Transbronchial Aspiration Needles; Biopsy Needles
3) By Pleuroscopes: Flexible Pleuroscopes; Semi-Rigid Pleuroscopes
4) By Airway Stents: Metallic Stents; Silicone Stents; Hybrid Stents
5) By Other Product Types: Bronchial Thermoplasty Devices; Lung Volume Reduction Devices; Electromagnetic Navigation Systems; Cryotherapy And Ablation Devices
Companies Mentioned: Johnson and Johnson; Siemens AG; Medtronic plc; FUJIFILM Holdings Corporation; GE Healthcare Technologies Inc.
3. Interventional Lung Solutions Market Trends And Strategies
4. Interventional Lung Solutions Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
5. Global Interventional Lung Solutions Growth Analysis And Strategic Analysis Framework
5.1. Global Interventional Lung Solutions PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Interventional Lung Solutions Market Growth Rate Analysis
5.4. Global Interventional Lung Solutions Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Interventional Lung Solutions Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Interventional Lung Solutions Total Addressable Market (TAM)
6.1. Global Interventional Lung Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Bronchoscopes
Endobronchial Ultrasound Needles
Pleuroscopes
Airway Stents
Other Product Types
6.2. Global Interventional Lung Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Robotic Surgery
Laser Therapy
Electromagnetic Navigation Bronchoscopy
6.3. Global Interventional Lung Solutions Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Bronchoscopy
Thoracoscopy
Pleuroscopy
Other Procedures
6.4. Global Interventional Lung Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Lung Cancer Treatment
Chronic Obstructive Pulmonary Disease
Sleep Apnea Treatment
6.5. Global Interventional Lung Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Ambulatory Surgical Centers
Specialty Clinics
Other End-Users
6.6. Global Interventional Lung Solutions Market, Sub-Segmentation Of Bronchoscopes, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Flexible Bronchoscopes
Rigid Bronchoscopes
Disposable Bronchoscopes
6.7. Global Interventional Lung Solutions Market, Sub-Segmentation Of Endobronchial Ultrasound Needles, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Transbronchial Aspiration Needles
Biopsy Needles
6.8. Global Interventional Lung Solutions Market, Sub-Segmentation Of Pleuroscopes, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Flexible Pleuroscopes
Semi-Rigid Pleuroscopes
6.9. Global Interventional Lung Solutions Market, Sub-Segmentation Of Airway Stents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Metallic Stents
Silicone Stents
Hybrid Stents
6.10. Global Interventional Lung Solutions Market, Sub-Segmentation Of Other Product Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Bronchial Thermoplasty Devices
Lung Volume Reduction Devices
Electromagnetic Navigation Systems
Cryotherapy And Ablation Devices
7. Interventional Lung Solutions Market Regional And Country Analysis
7.1. Global Interventional Lung Solutions Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Interventional Lung Solutions Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Interventional Lung Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Interventional Lung Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Interventional Lung Solutions Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Interventional Lung Solutions Market
9.1. China Interventional Lung Solutions Market Overview
9.2. China Interventional Lung Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Interventional Lung Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Interventional Lung Solutions Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Interventional Lung Solutions Market
10.1. India Interventional Lung Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Interventional Lung Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Interventional Lung Solutions Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Interventional Lung Solutions Market
11.1. Japan Interventional Lung Solutions Market Overview
11.2. Japan Interventional Lung Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Interventional Lung Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Interventional Lung Solutions Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Interventional Lung Solutions Market
12.1. Australia Interventional Lung Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Interventional Lung Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Interventional Lung Solutions Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Interventional Lung Solutions Market
13.1. Indonesia Interventional Lung Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Interventional Lung Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Interventional Lung Solutions Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Interventional Lung Solutions Market
14.1. South Korea Interventional Lung Solutions Market Overview
14.2. South Korea Interventional Lung Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Interventional Lung Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Interventional Lung Solutions Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Interventional Lung Solutions Market
15.1. Western Europe Interventional Lung Solutions Market Overview
15.2. Western Europe Interventional Lung Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Interventional Lung Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Interventional Lung Solutions Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Interventional Lung Solutions Market
16.1. UK Interventional Lung Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Interventional Lung Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Interventional Lung Solutions Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Interventional Lung Solutions Market
17.1. Germany Interventional Lung Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Interventional Lung Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Interventional Lung Solutions Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Interventional Lung Solutions Market
18.1. France Interventional Lung Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Interventional Lung Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Interventional Lung Solutions Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Interventional Lung Solutions Market
19.1. Italy Interventional Lung Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Interventional Lung Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Interventional Lung Solutions Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Interventional Lung Solutions Market
20.1. Spain Interventional Lung Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Interventional Lung Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Interventional Lung Solutions Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Interventional Lung Solutions Market
21.1. Eastern Europe Interventional Lung Solutions Market Overview
21.2. Eastern Europe Interventional Lung Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Interventional Lung Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Interventional Lung Solutions Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Interventional Lung Solutions Market
22.1. Russia Interventional Lung Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Interventional Lung Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Interventional Lung Solutions Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Interventional Lung Solutions Market
23.1. North America Interventional Lung Solutions Market Overview
23.2. North America Interventional Lung Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Interventional Lung Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Interventional Lung Solutions Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Interventional Lung Solutions Market
24.1. USA Interventional Lung Solutions Market Overview
24.2. USA Interventional Lung Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Interventional Lung Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Interventional Lung Solutions Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion